Affordability Check
How to afford Imlygic
Generic name: talimogene laherparepvec
Pick how you're covered. We'll show you the cheapest legitimate way to get Imlygic — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About Imlygic and its cost
What is this medication? Imlygic, also known by its generic name talimogene laherparepvec, is a prescription medication used to treat a type of skin cancer called melanoma. Specifically, it is designed for patients who have melanoma lesions in their skin or lymph nodes that cannot be completely removed through surgery. It is a genetically modified version of the herpes simplex virus type 1, making it a specialized type of treatment called an oncolytic immunotherapy. This medication is administered by a healthcare professional through direct injection into the cancerous tumors.
The medication works through two distinct mechanisms to fight the disease. First, it enters the melanoma cells and replicates, causing the cells to rupture and die. Second, as the cancer cells break apart, they release a protein along with tumor-specific antigens. This process helps the patient’s own immune system recognize and attack cancer cells throughout the body. While it is injected locally into specific lesions, the immune response it triggers is intended to help the body target melanoma cells beyond the specific site of the injection.
Imlygic is made by Amgen. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford Imlygic?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for Imlygic?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Amgen has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover Imlygic?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Melanoma?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about Imlygic
Full Imlygic drug page
FDA label, prior authorization rules, full indications list
More options for Melanoma
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3